Please consider the offer document and general risk warning before investing.
Investors are entitled to a 5 day cooling-off period.
Investments over $10,000 are restricted to Sophisticated investors - Apply here
Click here to learn more about Equity Crowdfunding
Here’s a behind the scenes tour of Cogniss’ app-building platform.
This week, we sat down with Leon Young, CEO & Founder of Cogniss, to ask questions that OnMarket investors submitted. Watch Leon’s answers to the crowd for a comprehensive insight into Cogniss!
Last year 25% of the 325,000 new apps published in the app store were transformational in nature - these are smart apps that help us transform our lives across lifestyle, health, fitness, wellbeing and education.
The best and most effective apps in these categories are call Human Transformation apps, as they use evidence-based neuropsychology to make a positive transformative impact on human cognition, health and wellbeing.
As the world's first no-code platform for building sophisticated Human Transformation Technology digital solutions, Cogniss sits at the nexus of some of the fastest growing areas in technology –
While human transformation apps are proving to be effective and popular, building them requires a complex set of expertise in behaviour sciences, UX design and app development, as well as a practical experience in building learning and health applications. Hence, custom development of a human transformation app can cost $100K to $1 Million and take anywhere from 6 to 12 months.
The Cogniss team has productised its years of experience in building sophisticated health and learning applications into an intuitive no-code platform. Cogniss offers any non-technical person a remarkably easier, faster and cost-effective alternative to build a human transformation app.
Like Canva gives everyone the power to be a graphic designer, Cogniss gives anyone the opportunity to create an app that drives long-lasting learning, health and behaviour change outcomes.
Cogniss is an Application Platform as a Service (aPaaS) which adopts the same business model characteristics as a software-as-a-service (SaaS) business.
Cogniss licenses its centrally hosted software to customers via subscription plans, allowing them to develop, run, and manage applications without the complexity of building and maintaining the infrastructure typically associated with developing and launching an app. With low fixed costs and high margins, SaaS business models are highly scalable with recurring revenue and long customer lifecycles.
Cogniss has bootstrapped itself to profitability since 2016 and generated ~$1m in revenue in FY21 with a net profit after tax of over $115,000.
Over the last 5 years, Cogniss has acquired a reputable base of blue-chip customers, that includes multinationals, large non-profits and government departments. A majority of customers are academic researchers from seven leading universities and three independent research organisations. For new customers this acts as a proof of Cogniss's robustness and compliance with some of the most stringent ethical and security standards.
Since the focus so far has been on product development and establishing product-market fit, almost all Cogniss’s customers have been acquired through word-of-mouth. You can hear more here.
Cogniss has a three phase global growth strategy with planned business development and capital raising milestones. These funding rounds in combination with subscription revenue will be used to fuel penetration into new markets and support the ever increasing adoption of the platform. The successful execution of this strategy will position Cogniss as a leading player in global technology.
Build dominant market share in the research app sector in Australia whilst establishing global marquee enterprise customers.
Leverage connections, credibility and sales playbook developed to scale globally within the human research app market and establish global marquee customers in other verticals.
Expand in to other fast-emerging commercial and government verticals leveraging the connections, credibility and proof points established in the research market.
For more detailed information, please read the Capital Structure section of the offer document.
For more information, please read the Use of Funds section of the offer document.
Cogniss Holdings Pty Ltd is an early-stage company with the world-first platform helping people and organisations build apps that are designed to have a positive transformative effect on human cognition, health and wellbeing. As with any early-stage business, an investment in the Company should be seen as high-risk and speculative. A description of the main risks that may impact their business are listed in the offer document. Investors should read this section carefully before deciding to apply for shares under the Offer. There are also other, more general, risks associated with the Company (for example, competition, cyber security, insolvency and cashflow, reputation or the inability to sell their shares).
See the Risk section in the Offer Document for further information.
The Offer is subject to a Maximum Subscription amount of $2 million. If the Maximum Subscription is reached, the Offer will close early. Applications will be treated on a time priority basis and may be subject to scale back, so please fund your application as soon as possible
RISK WARNING: Crowd-sourced funding is risky. Issuers using this facility include new or rapidly growing ventures. Investment in these types of ventures is speculative and carries high risks. You may lose your entire investment, and you should be in a position to bear this risk without undue hardship. Even if the company is successful, the value of your investment and any return on the investment could be reduced if the company issues more shares. Your investment is unlikely to be liquid. This means you are unlikely to be able to sell your shares quickly or at all if you need the money or decide that this investment is not right for you.
Even though you have remedies for misleading statements in the replacement offer document or misconduct by the company, you may have difficulty recovering your money. There are rules for handling your money. However, if your money is handled inappropriately or the person operating this platform becomes insolvent, you may have difficulty recovering your money. Ask questions, read all information given carefully, and seek independent financial advice before committing yourself to any investment.
5 DAY COOLING OFF PERIOD: There is a 5 business day cooling off period for retail investors. During this period, you may withdraw your application and receive a full refund into your nominated refund account. Please note: After the 5 day cooling off period has expired, you will be unable to withdraw your application. More information here.
ONMARKET FEES: Upon successful completion of the Offer, a maximum fee of 6% of the funds raised will be paid to OnMarket by the Company.
ONMARKET INTERESTS: OnMarket and its associates may be participating in this offer.
ONMARKET INTERESTS AND AMOUNTS SUBJECT TO COOLING OFF: The funding bar displayed under each crowd funding offer may include applications where payments are yet to be made and amounts that are subject to the cooling off period.
Section 734(6) disclosure: The issuer of the securities is Cogniss Holdings Pty Ltd ACN 645 346 523. The securities to be issued are fully-paid ordinary shares. The disclosure document for the offer can be obtained by clicking on the link above. The offers of the securities are made in, or accompanied by, a copy of the disclosure document. Investors should consider the disclosure document in deciding whether to acquire the securities. Anyone who wants to acquire the securities will need to complete the application form that will be in or will accompany the disclosure document (which can be done via the electronic application form which will become available by clicking the bid button above)
Sawce.com.au is the FIRST and ONLY online marketplace dedicated to helping people furnish and fitout any space – home, commercial and office. Starting with over a hundred thousand products from hundreds of retailers, & targeting 1 million products within 12 months, they are the Domain.com and RealEstate.com of the $50B Australian furnishing and fitout industry.
Using their successful pilot site with 30,000 users a month as the base, Sawce.com.au launches in October, with rapid expansion anticipated as a pure-play technology-driven marketplace.
Before investing please consider the offer document and the general risk warning.
Commitments in excess of $7m min offer size. OnMarket has a limited allocation
ChemX Materials Limited (ASX: CMX) is a materials technology company developing new and innovative solutions to produce materials required for the global energy transition and de-carbonisation markets. The Company’s initial focus is in-house developed technology to process and supply High Purity Alumina (“HPA”). HPA is a critical material for the Lithium-Ion Battery and LED & Semiconductor markets. ChemX is planning to construct a pilot plant within 12-18 months.
The Company also holds two exploration licences in the Eyre Peninsula, South Australia which are prospective for kaolin / halloysite and manganese, key materials for the decarbonisation of industrial processes, Hydrogen storage, CO2 Capture and battery precursor material.
Belararox Limited (ASX: BRX) is an Australian mineral explorer focused on securing and developing resources to meet the surge in demand from the technology, battery and renewable energy markets.
The Company directly owns 100% of the Belara metals project in NSW that comprises a granted exploration licence and two exploration licence applications, and the Bullabulling gold and nickel project located Western Australia that comprises a package of 26 granted prospecting licences located close to the Bullabulling Gold Mine.
The Belara Project is a highly prospective near-term base metal opportunity. Previous drilling has shown mineralisation with excellent continuity, containing significant intersections of zinc, copper, silver, lead and gold and is located close to well-developed infrastructure.
Dragonfly Biosciences Limited’s (ASX: DRF) develops cannabidiol (CBD) health and wellness products derived from the cannabis plant, owning and operating the entire production chain from ‘seed to shelf’. EU licensed strains are grown on its own organically certified fields in the EU, with CBD extraction undertaken at the Company’s ‘state of the art’ large scale extraction facility.
Dragonfly has a 3-year track record of selling its CBD products through blue chip retailers in the United Kingdom (UK), such as Boots, Tesco, Sainsbury’s, Amazon and Harrods, and is now targeting international expansion to Australia, Asia Pacific and the USA. The company is forecasting revenues of $6.9 million for FY2021.
Kredible is the next generation of talent search platforms, completely flipping the hiring process on it’s head by offering employers a searchable database of professionals who have all been verified by their previous employers via extensive reference checks, all displayed in an Uber-style review format.
Currently, almost all businesses conduct talent searches through job boards or recruitment agencies via a lengthy, expensive and highly inefficient process. Kredible aims to fix this by offering employers a technology enabled platform to hire talent considerably faster, cheaper and with much more accuracy.
Disrupting this process represents a contestable revenue opportunity of over $12 billion in Australia alone.
Before investing please consider the offer document and the general risk warning
Every year over 419 million handheld batteries are sold in Australia and just 4% of these are recycled with the rest going to landfill. As batteries begin to break down in landfill, heavy metals can leach into the surface and groundwater, polluting our soils and waterways.
ReNutrients is on a mission to address the issue of battery waste in Australia whilst returning the valuable minerals used in the batteries to the ground. Via their exclusive distribution agreement with Finnish cleantech company, Tracegrow, ReNutrients has a suite of organic fertilisers made from recycled batteries that have shown increased yields for growers by up to 26% compared to traditional competing products.
Before investing please consider the offer document and the general risk warning.